These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22490761)

  • 1. No significant improvement of cardiovascular disease risk indicators by a lifestyle intervention in people with familial hypercholesterolemia compared to usual care: results of a randomised controlled trial.
    Broekhuizen K; van Poppel MN; Koppes LL; Kindt I; Brug J; van Mechelen W
    BMC Res Notes; 2012 Jul; 5():181. PubMed ID: 22490761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tailored lifestyle intervention to reduce the cardiovascular disease risk of individuals with Familial Hypercholesterolemia (FH): design of the PRO-FIT randomised controlled trial.
    Broekhuizen K; van Poppel MN; Koppes LL; Brug J; van Mechelen W
    BMC Public Health; 2010 Feb; 10():69. PubMed ID: 20156339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lifestyle intervention improve cardiovascular disease risk factors in community-based menopausal transition and early postmenopausal women in China.
    Wu L; Chen R; Ma D; Zhang S; Walton-Moss B; He Z
    Menopause; 2014 Dec; 21(12):1263-8. PubMed ID: 24781851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can multiple lifestyle behaviours be improved in people with familial hypercholesterolemia? Results of a parallel randomised controlled trial.
    Broekhuizen K; van Poppel MN; Koppes LL; Kindt I; Brug J; van Mechelen W
    PLoS One; 2012; 7(12):e50032. PubMed ID: 23251355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the process of delivery of an individually tailored lifestyle intervention associated with improvements in LDL cholesterol and multiple lifestyle behaviours in people with familial hypercholesterolemia?
    Broekhuizen K; Jelsma JG; van Poppel MN; Koppes LL; Brug J; van Mechelen W
    BMC Public Health; 2012 May; 12():348. PubMed ID: 22583789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Effectiveness of Individually Tailored Lifestyle Intervention in Patients With Familial Hypercholesterolemia.
    Beyece İncazli S; Özer S; Kayikçioğlu M
    J Cardiovasc Nurs; 2022 Sep-Oct 01; 37(5):465-474. PubMed ID: 35952313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a comprehensive lifestyle intervention on cardiovascular risk factors in pharmacologically treated patients with stable cardiovascular disease compared to usual care: a randomised controlled trial.
    Ijzelenberg W; Hellemans IM; van Tulder MW; Heymans MW; Rauwerda JA; van Rossum AC; Seidell JC
    BMC Cardiovasc Disord; 2012 Sep; 12():71. PubMed ID: 22962863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-soluble-fiber foods in conjunction with a telephone-based, personalized behavior change support service result in favorable changes in lipids and lifestyles after 7 weeks.
    Kris-Etherton PM; Taylor DS; Smiciklas-Wright H; Mitchell DC; Bekhuis TC; Olson BH; Slonim AB
    J Am Diet Assoc; 2002 Apr; 102(4):503-10. PubMed ID: 11985406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lifestyle interventions on cardiovascular risk factors among adults without impaired glucose tolerance or diabetes: A systematic review and meta-analysis.
    Zhang X; Devlin HM; Smith B; Imperatore G; Thomas W; Lobelo F; Ali MK; Norris K; Gruss S; Bardenheier B; Cho P; Garcia de Quevedo I; Mudaliar U; Jones CD; Durthaler JM; Saaddine J; Geiss LS; Gregg EW
    PLoS One; 2017; 12(5):e0176436. PubMed ID: 28493887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lifestyle intervention on cardiometabolic risk factors: results of the POWER-UP trial.
    Vetter ML; Wadden TA; Chittams J; Diewald LK; Panigrahi E; Volger S; Sarwer DB; Moore RH;
    Int J Obes (Lond); 2013 Aug; 37 Suppl 1(0 1):S19-24. PubMed ID: 23921777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.
    ; Wing RR
    Arch Intern Med; 2010 Sep; 170(17):1566-75. PubMed ID: 20876408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia.
    Ravnskov U; de Lorgeril M; Kendrick M; Diamond DM
    Med Hypotheses; 2018 Dec; 121():60-63. PubMed ID: 30396495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk factor profiles in familial hypercholesterolemia patients with and without genetic mutation compared to a nationally representative sample of adults in a high-risk European country.
    Chlebus K; Zdrojewski T; Gruchała M; Gałąska R; Pajkowski M; Kocejko MR; Chmara M; Pencina MJ
    Am Heart J; 2019 Dec; 218():32-45. PubMed ID: 31706143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family-centered brief intervention for reducing obesity and cardiovascular disease risk: A randomized controlled trial.
    Duncan S; Goodyear-Smith F; McPhee J; Zinn C; Grøntved A; Schofield G
    Obesity (Silver Spring); 2016 Nov; 24(11):2311-2318. PubMed ID: 27616217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of multidisciplinary patient counselling in reducing cardiovascular disease risk factors through nonpharmacological intervention: results from the Healthy Heart Program.
    Simpson DR; Dixon BG; Bolli P;
    Can J Cardiol; 2004 Feb; 20(2):177-86. PubMed ID: 15010741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an intervention to improve the cardiovascular health of family members of patients with coronary artery disease: a randomized trial.
    Reid RD; McDonnell LA; Riley DL; Mark AE; Mosca L; Beaton L; Papadakis S; Blanchard CM; Mochari-Greenberger H; O'Farrell P; Wells GA; Slovinec D'Angelo ME; Pipe AL
    CMAJ; 2014 Jan; 186(1):23-30. PubMed ID: 24246588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
    Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW
    Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
    Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
    Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An economic evaluation alongside a randomized controlled trial evaluating an individually tailored lifestyle intervention compared with usual care in people with familial hypercholesterolemia.
    Broekhuizen K; van Wier MF; Koppes LL; Brug J; van Mechelen W; Bosmans JE; van Poppel MN
    BMC Res Notes; 2015 Jul; 8():317. PubMed ID: 26219281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Before-and-After Workplace Intervention to Promote Healthy Lifestyles in Healthcare Workers (STI-VI Study): Short-Term Assessment.
    Scapellato ML; Comiati V; Buja A; Buttignol G; Valentini R; Burati V; La Serra L; Maccà I; Mason P; Scopa P; Volpin A; Trevisan A; Spinella P
    Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30235849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.